Cure for acquired immunodeficiency syndrome—A global battle

Jie Wang

doi:10.1007/s11655-013-1571-y

Your Location：

Home >

Browse articles >

Cure for acquired immunodeficiency syndrome—A global battle

OriginalPaper | Updated：2021-08-27

- Cure for acquired immunodeficiency syndrome—A global battle
- Cure for acquired immunodeficiency syndrome—A global battle
- 中国结合医学杂志（英文版） 2014年20卷第2期页码：83-87
- Affiliations：
  
  Guang’anmen Hospital, China Academy of Chinese Medical Sciences,Beijing,China
- Author bio：
- Funds：
  
  Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV). It has ravaged everywhere in the world and has seriously jeopardized people’s physical and mental health and their lives since the first case was announced by the US Center for Disease Control in 1981.
- DOI：10.1007/s11655-013-1571-y
  中图分类号：
- 纸质出版日期：2014，
  
  网络出版日期：2013-12-18，
Scan for full text
Wang, J. Cure for acquired immunodeficiency syndrome—A global battle., Chin. J. Integr. Med. 20, 83–87 (2014). https://doi.org/10.1007/s11655-013-1571-y

Jie Wang. Cure for acquired immunodeficiency syndrome—A global battle[J]. Chinese Journal of Integrative Medicine, 2014,20(2):83-87.
Wang, J. Cure for acquired immunodeficiency syndrome—A global battle., Chin. J. Integr. Med. 20, 83–87 (2014). https://doi.org/10.1007/s11655-013-1571-y DOI：

Jie Wang. Cure for acquired immunodeficiency syndrome—A global battle[J]. Chinese Journal of Integrative Medicine, 2014,20(2):83-87. DOI： 10.1007/s11655-013-1571-y.

摘要

Abstract

关键词

human immunodeficiency virusHuman Immunodeficiency Virus InfectionUnprotected Sexual ActivityIntegrase InhibitorElvitegravir

Keywords

human immunodeficiency virusHuman Immunodeficiency Virus InfectionUnprotected Sexual ActivityIntegrase InhibitorElvitegravir

references

WHO/UNAIDS. AIDS epidemic update 2004. http://www.unaids.org.en.

Wayne CK, Berkley SF. The renaissance in HIV vaccine development—future directions. N Engl J Med 2010;363:e7.

Kvitsinadze L, Tvildiani D, Pkhakadze G. HIV/AIDS prevalence in the southern caucasus. Georgian Med News 2010;189:26–36.

Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, Prins M, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011;25:493–501.

Zhang YH, Bao YG, Sun JP, Tan HZ. Analysis of HIV/Syphilis/HCV infection among drug users in 15 cities, China. Chin J Prevent Med (Chin) 2010;44:969–974.

Lei N, Peng ZH, Huan XP, Chen X, Yu RB, Yang HT. Estimation and prediction of the epidemic situation of acquired immunodeficiency syndrome in Jiangsu province. Chin J Prevent Med (Chin). 2010;44:1012–1017.

Jia M, Luo H, Ma Y, Wang N, Smith K, Mei J, et al. The HIV epidemic in Yunnan Province, China, 1989–2007. J Acquir Immune Defic Syndr 2010;53(Suppl 1):S34–S40.

Mildvan D, Mathur U, Enlow RW, Romain PL, Winchester RJ, Colp C, et al. Opportunistic infections and immune def iciency in homosexual men. Ann Intern Med 1982;96:700–704.

Vilcek J. Boosting p53 with interferon and viruses. Nat Immunol 2003;4:825–826.

Piacentini L, Biasin M, Fenizia C, Clerici M. Genetic correlates of protection against HIV infection: the ally within. J Intern Med 2008;265:110–124.

Boasso A, Shearer GM, Chougnet C. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? J Intern Med 2009;265:78–96.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209–2220.

Alcaro S, Alteri C, Artese A, Ceccherini-Silberstein F, Costa G, Ortuso F, et al. Molecular and structural aspects of clinically relevant mutations related to the approved nonnucleoside inhibitors of HIV-1 reverse transcriptase. Drug Resist Updat 2011;14:141–149.

Al-Mawsawi LQ, Neamati N. Al loster ic Inhibi tor development targeting HIV-1 integrase. Chem Med Chem 2011;6:228–241.

Rhame FS. When to start antiretroviral therapy. Curr Infect Dis Rep 2011;13:60–67.

Wang J, Lin HS, Liu MY, Li Y. Immune reconstitution of acquired immune deficiency syndrome. Chin J Integr Med 2010;16:557–64.

Luo SD, Fan DQ, Wang HY, eds. Activity of herbal meidicine in anti-HIV: Kunming: Yunnan Scientific and Technology Publishing House; 1998:6.

Xu HX, Wan M, Loh BN, Kon OL, Chow PW, Sim KY. Screening of traditional medicines for their inhibitory activity against HIV-1 protease. Phytotherapy Res 1996;10:207–210.

Ma BY, Fu LC, Chen XJ. Progress of single and compound herbal medicine in anti-HIV. Tradit Chin Med Inform (Chin) 2007;24:17–20.

Guan CF, Wang J, Xu SL. Clinical and experiment studies on Zhongyan II in HIV/A1DS treatment. Chin J Integr Tradit West Med (Chin) 2003;23:494–497.

Guo HJ, Liu XW, Wang DN. The effects of Fuzheng Paidu I in treating asymptomatic HIV infection. Shanghai Tradit Chin Med (Chin) 2006;40:20–21.

Peng B, Wang DN. Clinical observation on 65 cases of asymptomatic HIV infection treated by Fuzheng PaiduII. J Tradit Chin Med (Chin) 2006;24:1781–1783.

FULL TEXT LINK

More>

浏览量

867

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Treatment of acquired immunodeficiency syndrome with chinese medicine in China: Opportunity, advancement and challenges

Fighting against acquired immunodeficiency syndrome with Chinese medicine: A perspective from China

Immune reconstitution—the footing of chinese medicine treatment for acquired immunodeficiency syndrome

Effect of traditional Chinese medicine for treating human immunodeficiency virus infections and acquired immune deficiency syndrome: Boosting immune and alleviating symptoms